Search
Log in
Sign up
Watch fullscreen
Biogen Plunges After FDA Says No to Alzheimer's Treatment
The Street
Follow
Like
Bookmark
Share
Add to Playlist
Report
5 years ago
Biogen stock plunges more than 30% after a Food and Drug Administration panel committee rules against giving the company's Alzheimer's drug the nod.
Category
🥇
Sports
Show less
Recommended
2:05
|
Up next
FDA approves new non-opioid painkiller
The Street
1:30
FDA approves new Alzheimer’s drug from Eli Lilly
The Street
0:43
FDA Approves First Drug to Target Genetic Cause of ALS
Benzinga
0:39
FDA Approves Eli Lilly's Alzheimer's Drug, Slowing the Progression of the Brain-Wasting Disease
Benzinga
10:41
Novel Therapy Shows Promising Results In On-Going Trials, Receives 3 Orphan Drug Designations From The FDA
Benzinga
1:31
New Drug Shows Promising Results in Fight Against Alzheimer's
Wibbitz Top Stories
1:00
Medical advancements: New drug found to slow decline of Alzheimer’s by 35% in trial
Local TV
0:47
Lilly Alzheimer's drug fails in big study
Wibbitz Top Stories
0:48
Biogen Alzheimer's drug closer to approval
PDA Media
16:00
This Biotech Just Cleared A Big FDA Hurdle In Its Quest To Improve ADHD Treatment
Benzinga
3:50
Landmark trial shows new drug can slow Alzheimer’s disease
ABC NEWS (Australia)
2:24
Biggest Pharmaceuticals Mergers And Acquisition in History
The Street
5:04
Families impacted by Alzheimer's express concerns over new drug Leqembi
23ABC News
0:42
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks
Benzinga
1:49
Drug trial shows treatment slows progress of disease
ABC NEWS (Australia)
1:58
Dementia At the End of Life: What are the medications?
Healthfeedspanish
1:00
Alzheimer's: New drug dubbed 'beginning of the end' in search for treatment
National World - LocalTV
0:48
New drug breakthrough gives hope for those with Alzheimer's
ODN
1:39
Pop Culture Fatigue: Enough of Taylor Swift & NFL Stars
SportsGrid
0:35
Purdue's Tough Game: Missed Shots and Overtime Possibility
SportsGrid
1:23
The Phoenix Suns Struggle in the NBA: A Detailed Analysis
SportsGrid
0:43
Levi Reports Strong Q4 Earnings but Warns of Weaker Sales Outlook for the Year
Benzinga
0:39
Consumer Groups Urge Trump To Keep AI Safety Rules, Warn Of Risks To Veterans And Retirees
Benzinga
0:42
UPS Stock Drops 15% as Company Cuts Amazon Deliveries by Over 50% and Issues Weak Revenue Guidance
Benzinga
1:18
A New Find in Israel That Is Stumping Archeologists
Amaze Lab